NEXMD NexMed, Inc

[Weirdharold]

NexMed is an innovative drug developer that is leveraging its proprietary NexACT® drug delivery technology to produce a host of new medical treatments. NexMed’s drugs address a variety of health conditions, such as nail fungus, ****** disorders and more.

NexMed is not so much a pharmaceutical company, per say, rather a drug delivery technology (NexACT®) company. A company that has been hit a couple tough blows recently... dropping their price per share form the $1.50 range down to $0.14 on Monday.

Recently Vitaros (a topical erectile dysfunction cream) received a non approval letter from the FDA. The major regulatory issues raised by the FDA were related to the results of the transgenic mouse carcinogenicity study which NexMed completed in 2002.

Although the non approval letter is a setback it is based upon data which the FDA is moving away from, and two different two year studies that disputes the transgenic mouse carcinogenicity study has yet to be presented to the FDA, but will be presented in October during a guidance meeting with the FDA., NexMed, and Warner Chilcott (the pharmaceutical company NexMed has the licensing agreement with for Vitaros)

The set back which was announced Monday was Novartis International Pharmaceutical's decision not to submit a New Drug Application for NM100060 (a topical application of terbinafine formulated with NexACT® for the treatment of onychomycosis, nail fungus,) with the Food and Drug Administration at this time.

It is important to note that Novartis has not pulled the plug on NM100060 and is still going forward with a European comparator study while deciding on a better testing procedure for the U.S. market.

A third drug Femprox®, a topical treatment for female ****** arousal disorder, has obtained positive results in a 400-patient study conducted in China in addition to a U.S. Phase 2 study.

I have to admit that the one - two punch of disappointment is troubling; it is not insurmountable, and certainly should not have had the affect of driving the price per share down to .14! This is NOT a pinksheet or even an OTC stock... it is a Nasdaq GM stock which I believe has a very good chance of recovery.

[sg1efc]

Chart:

NEXM - SharpCharts from StockCharts.com

Maybe good for a bounce play.... if not a possible longer term stock to hold. Think it has hit bottom?

[mike_d]

I am in for a few at .18ish well see what happens.

[BadThad]

Nice find, I think it's at it's bottom. Only concern is the volume is a bit light, but this looks like a solid bottom play. These kinds of stocks can be absolute rocketships. All it takes is a little good news to send them flying. There's a good chance of a 10x return on this stock based on history.

[BadThad]

I took a modest position just now, let's just see how it pans out.

[Weirdharold]

always helps my feeling when you join the party on one of "these kind" of stocks. I missed those .14's yesterday.... .17 here.

[BadThad]

Originally Posted by Weirdharold

always helps my feeling when you join the party on one of "these kind" of stocks. I missed those .14's yesterday.... .17 here.

LOL....don't get too warm and fuzzy, I make my share of mistakes.

So far, I really think this is bottom for this stock. However, I don't think it's going to rebound anytime soon. That's why I only bought 3k shares....just let it sit in the oven to bake. Hey, I'm already up $12! LOL

[Weirdharold]

yeah, me too... only 10k to sit a while waiting on the yeast reaction.

[mike_d]

anyone thinking the bottom is still yet to be found. I am going to hold what I have I suppose, but might average down if it continues to get a little cheaper.

Turns out I have pretty much drained my scottrade account the past few months, it kills me being in Hawaii bc of time difference then not being around the computer bc of work doesnt help. I might have to sit on this one for a while.

How long does a company have to get back over a dollar before getting delisted?

[soupcan]

got in at .12. Hopefully it's settled down and ready for the move up